Interestingly, the levels of IL-6 and the nuclear translocation of NF-κB were both evidently decreased by PAL, one of the most active metabolites of SABP in myocardial ischemia/reperfusion injury (Wang et al., 2021b). The gene discussed is NFKB1; the disease is myocardial ischemia.